I am Garima Joshi, a Ph.D. scholar at the Regional Centre for Biotechnology (RCB) and a senior research fellow. My research focuses on combating post-acute COVID-19 complications, particularly pulmonary inflammation and fibrosis, through alpha-ketoglutarate supplementation. To advance this work, I have developed a unique SARS-CoV-2-induced ARDS mice model, providing new insights into these conditions. With four publications—three research articles and a review—I am committed to advancing scientific knowledge and sharing my findings. I actively engage in scientific conferences, including the IUBMB RNA Virus Meeting (2022) and a Human Microbiome Conference with a next-generation sequencing workshop (2023). These events have enriched my research perspective and facilitated valuable professional connections.